ALX Oncology
ALXO
ALXO
104 hedge funds and large institutions have $1.82B invested in ALX Oncology in 2021 Q2 according to their latest regulatory filings, with 22 funds opening new positions, 38 increasing their positions, 26 reducing their positions, and 11 closing their positions.
New
Increased
Maintained
Reduced
Closed
more call options, than puts
Call options by funds: $ | Put options by funds: $
more first-time investments, than exits
New positions opened: | Existing positions closed:
more repeat investments, than reductions
Existing positions increased: | Existing positions reduced:
more funds holding
Funds holding: →
0.7% less ownership
Funds ownership: 83.51% → 82.81% (-0.7%)
26% less capital invested
Capital invested by funds: $2.47B → $1.82B (-$646M)
33% less funds holding in top 10
Funds holding in top 10: 6 → 4 (-2)
Holders
104
Holding in Top 10
4
Calls
$3.16M
Puts
$815K
Top Buyers
| 1 | +$19.1M | |
| 2 | +$12.9M | |
| 3 | +$10.5M | |
| 4 |
State Street
Boston,
Massachusetts
|
+$6.97M |
| 5 |
Morgan Stanley
New York
|
+$5.27M |
Top Sellers
| 1 | -$58M | |
| 2 | -$14.6M | |
| 3 | -$14.2M | |
| 4 |
Janus Henderson Group
London,
United Kingdom
|
-$8.11M |
| 5 |
Goldman Sachs
New York
|
-$6.4M |